LNTH FY 2016 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$5B

FY 2016 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$302M+2.9% YoY

Gross Profit

$138M45.6% margin

Operating Income

$57M18.7% margin

Net Income

$27M8.9% margin

EPS (Diluted)

$0.82

Cash Flow

Operating Cash Flow

$50M

Free Cash Flow

$42M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$256M

Total Liabilities

$362M

Stockholders' Equity

-$107M

Cash & Equivalents

$51M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$302M	$293M	+2.9%
Gross Profit	$138M	$136M	+1.7%
Operating Income	$57M	$43M	+33.1%
Net Income	$27M	-$15M	+281.5%